Table 1.
Number of cancer cases identified and included in analysis 1995–2014 by cancer site and country
| Cases identified |
Exclusion criteria |
Cases included in analyses | ||||
|---|---|---|---|---|---|---|
| Diagnosed on the basis of death certificate or autopsy | Quality control* | Age <15 years or >99 years | Multiple cancers | |||
| Oesophagus | ||||||
| Australia | 15 313 | 193 (1·25%) | 77 (0·50%) | 3 (0·02%) | 9 (0·06%) | 15 032 (98·16%) |
| Canada | 23 560 | 309 (1·31%) | 12 (0·05%) | 7 (0·03%) | 43 (0·18%) | 23 189 (98·43%) |
| Denmark | 8296 | 94 (1·13%) | 0 | 2 (0·02%) | 4 (0·05%) | 8196 (98·79%) |
| Ireland | 6471 | 107 (1·65%) | 0 | 1 (0·02%) | 7 (0·11%) | 6356 (98·22%) |
| New Zealand | 4943 | 33 (0·67%) | 1 (0·02%) | 2 (0·04%) | 1 (0·02%) | 4906 (99·25%) |
| Norway | 3988 | 47 (1·18%) | 0 | 1 (0·03%) | 4 (0·10%) | 3936 (98·70%) |
| UK | 156 125 | 2137 (1·32%) | 5 (<0·01%) | 72 (0·05%) | 115 (0·07%) | 153 877 (98·56%) |
| Stomach | ||||||
| Australia | 26 282 | 294 (1·12%) | 124 (0·47%) | 12 (0·05%) | 51 (0·19%) | 25 801 (98·17%) |
| Canada | 43 370 | 607 (1·40%) | 17 (0·04%) | 10 (0·02%) | 93 (0·21%) | 42 643 (98·32%) |
| Denmark | 10 745 | 159 (1·48%) | 0 | 4 (0·04%) | 3 (0·03%) | 10 579 (98·46%) |
| Ireland | 9413 | 276 (2·93%) | 0 | 1 (0·01%) | 18 (0·19%) | 9118 (96·87%) |
| New Zealand | 7635 | 69 (0·90%) | 2 (0·03%) | 7 (0·09%) | 1 (0·01%) | 7556 (98·97%) |
| Norway | 11 255 | 134 (1·19%) | 0 | 4 (0·04%) | 18 (0·16%) | 11 099 (98·61%) |
| UK | 170 448 | 3454 (1·94%) | 16 (0·01%) | 94 (0·06%) | 216 (0·13%) | 166 812 (97·87%) |
| Colon | ||||||
| Australia | 126 281 | 1291 (1·02%) | 584 (0·46%) | 95 (0·08%) | 4244 (3·36%) | 120 067 (95·08%) |
| Canada | 210 013 | 2321 (1·11%) | 93 (0·04%) | 85 (0·04%) | 3433 (1·63%) | 204 081 (97·18%) |
| Denmark | 51 821 | 444 (0·86%) | 0 | 24 (0·05%) | 447 (0·86%) | 50 906 (98·23%) |
| Ireland | 29 026 | 618 (2·13%) | 1 (<0·01%) | 11 (0·04%) | 852 (2·94%) | 27 544 (94·89%) |
| New Zealand | 40 408 | 245 (0·61%) | 1 (<0·01%) | 13 (0·03%) | 58 (0·14%) | 40 091 (99·22%) |
| Norway | 48 748 | 540 (1·11%) | 116 (0·24%) | 23 (0·05%) | 824 (1·69%) | 47 245 (96·92%) |
| UK | 540 800 | 8955 (1·60%) | 45 (0·01%) | 638 (0·12%) | 14 249 (2·64%) | 517 231 (95·64%) |
| Rectum | ||||||
| Australia | 45 562 | 213 (0·47%) | 102 (0·22%) | 8 (0·02%) | 1195 (2·62%) | 44 044 (96·67%) |
| Canada | 66 449 | 416 (0·63%) | 22 (0·03%) | 20 (0·03%) | 1075 (1·62%) | 64 916 (97·69%) |
| Denmark | 26 173 | 172 (0·66%) | 0 | 7 (0·03%) | 290 (1·11%) | 25 704 (98·21%) |
| Ireland | 11 235 | 121 (1·08%) | 0 | 2 (0·02%) | 202 (1·80%) | 10 910 (97·11%) |
| New Zealand | 13 369 | 65 (0·49%) | 3 (0·02%) | 8 (0·06%) | 243 (1·82%) | 13 050 (97·61%) |
| Norway | 20 557 | 98 (0·48%) | 0 | 7 (0·03%) | 486 (2·36%) | 19 966 (97·13%) |
| UK | 210 073 | 2214 (1·02%) | 14 (0·01%) | 89 (0·04%) | 3232 (1·54%) | 204 586 (97·39%) |
| Pancreas | ||||||
| Australia | 29 636 | 1054 (3·56%) | 599 (2·02%) | 19 (0·06%) | 5 (0·02%) | 27 959 (94·34%) |
| Canada | 53 922 | 2116 (3·92%) | 42 (0·08%) | 34 (0·06%) | 12 (0·02%) | 51 718 (95·91%) |
| Denmark | 16 676 | 411 (2·46%) | 0 | 3 (0·02%) | 1 (0·01%) | 16 261 (97·51%) |
| Ireland | 7922 | 382 (4·82%) | 0 | 2 (0·03%) | 9 (0·11%) | 7529 (95·04%) |
| New Zealand | 8011 | 187 (2·33%) | 2 (0·02%) | 12 (0·15%) | 0 | 7810 (97·49%) |
| Norway | 13 188 | 487 (3·69%) | 0 | 4 (0·03%) | 3 (0·02%) | 12 694 (96·25%) |
| UK | 157 641 | 6623 (4·05%) | 15 (0·01%) | 110 (0·07%) | 70 (0·04%) | 151 064 (95·83%) |
| Lung | ||||||
| Australia | 119 915 | 2826 (2·36%) | 1234 (1·03%) | 36 (0·03%) | 727 (0·61%) | 115 092 (95·98%) |
| Canada | 304 284 | 6818 (2·24%) | 175 (0·06%) | 55 (0·02%) | 2445 (0·80%) | 294 791 (96·88%) |
| Denmark | 79 731 | 1591 (2·00%) | 0 | 7 (0·01%) | 140 (0·18%) | 77 993 (97·82%) |
| Ireland | 35 659 | 1200 (3·37%) | 4 (0·01%) | 7 (0·02%) | 306 (0·86%) | 34 142 (95·75%) |
| New Zealand | 35 666 | 720 (2·02%) | 2 (0·01%) | 8 (0·02%) | 14 (0·04%) | 34 922 (97·91%) |
| Norway | 47 872 | 938 (1·96%) | 0 | 8 (0·02%) | 321 (0·67%) | 46 605 (97·35%) |
| UK | 821 586 | 22 709 (2·63%) | 667 (0·08%) | 209 (0·03%) | 5567 (0·68%) | 793 535 (96·59%) |
| Ovary | ||||||
| Australia | 18 004 | 275 (1·53%) | 119 (0·66%) | 72 (0·40%) | 56 (0·31%) | 17 482 (97·10%) |
| Canada | 39 030 | 546 (1·40%) | 11 (0·03%) | 153 (0·39%) | 107 (0·27%) | 38 213 (97·91%) |
| Denmark | 11 810 | 105 (0·89%) | 0 | 17 (0·14%) | 64 (0·54%) | 11 624 (98·43%) |
| Ireland | 6517 | 147 (2·26%) | 1 (0·02%) | 15 (0·23%) | 22 (0·34%) | 6332 (97·16%) |
| New Zealand | 5796 | 47 (0·81%) | 1 (0·02%) | 29 (0·50%) | 12 (0·21%) | 5707 (98·46%) |
| Norway | 9960 | 116 (1·16%) | 16 (0·16%) | 25 (0·25%) | 36 (0·36%) | 9767 (98·06%) |
| UK | 129 748 | 2655 (1·98%) | 348 (0·27%) | 363 (0·28%) | 574 (0·44%) | 125 892 (97·03%) |
Data are n or n (%). Proportions are calculated using the number of cases identified as the denominator.
*
Data inconsistencies included invalid age, missing or incomplete dates, tumours with non-malignant behaviour, and tumours with invalid morphological or topographical codes.